Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Reviews in Endocrine and Metabolic Disorders

Issue 2/2013

"HIV Related Endocrinopathies" and "Mass Spectrometry in Endocrinology"

Content (11 Articles)

Endocrinopathies in HIV, AIDS and HAART

Amrit Bhangoo, Ninad Desai

Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis

Minu M. George, Amrit Bhangoo

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS

Shobhit Jain, Ninad Desai, Amrit Bhangoo

Bone and vitamin D metabolism in HIV

Aristotle Panayiotopoulos, Nandini Bhat, Amrit Bhangoo

HIV and thyroid dysfunction

Alan A. Parsa, Amrit Bhangoo

Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS

Ovidiu Galescu, Amrit Bhangoo, Svetlana Ten

Insights into tandem mass spectrometry for the laboratory endocrinology

Uberto Pagotto, Flaminia Fanelli, Renato Pasquali

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis

Phillip J. Monaghan, Brian G. Keevil, Peter J. Trainer

Vitamin D and metabolites measurement by tandem mass spectrometry

Johannes M. W. van den Ouweland, Michael Vogeser, Silvia Bächer

Revisiting hyper- and hypo-androgenism by tandem mass spectrometry

Flaminia Fanelli, Alessandra Gambineri, Marco Mezzullo, Valentina Vicennati, Carla Pelusi, Renato Pasquali, Uberto Pagotto

The role of endothelial insulin signaling in the regulation of glucose metabolism

Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki

Mar 13
Issue: 1/2013
Vascular Endothelium in Diabetes and its Potential as a Therapeutic Target
Sep 13
Issue: 3/2013
Nutrition and Metabolic Syndrome

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits